Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1164 | 1030 | 1164 | 1080 | 1610 | 2570 |
Fund Return | 16.41% | 3.02% | 16.41% | 2.59% | 10% | 9.9% |
Place in category | 331 | 288 | 331 | 461 | 264 | 79 |
% in Category | 69 | 53 | 69 | 97 | 55 | 20 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Glbl Eq Cl Sr F | 7.35B | 10.85 | 5.10 | 10.86 | ||
Manulife Glbl Eq Cl Sr FT6 | 7.35B | 10.86 | 5.10 | 10.87 | ||
Manulife Glbl Eq Cl Sr T6 | 7.35B | 9.50 | 3.81 | 9.50 | ||
Manulife Glbl Eq Cl Sr Adv | 7.35B | 9.50 | 3.82 | 9.51 | ||
Manulife Div incm Fd Sr Adv | 6.83B | 15.11 | 1.45 | 8.68 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Fidelity Canadian Growth Comp Sr A | 12.21B | 35.60 | 12.30 | 13.69 | ||
Fidelity Canadian Growth Comp Sr F | 12.21B | 37.48 | 13.85 | 15.24 | ||
Fidelity Canadian Growth Comp Sr B | 12.21B | 35.91 | 12.56 | 13.93 | ||
Fidelity Canadian Large Cap Sr F | 8.58B | 16.11 | 12.13 | 9.78 | ||
Fidelity Canadian Large Cap Sr F5 | 8.58B | 16.13 | 12.15 | 9.79 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Constellation Software | CA21037X1006 | 4.03 | 4,563.27 | +1.41% | |
Fidelity National Info | US31620M1062 | 4.00 | 79.29 | +0.98% | |
Alphabet A | US02079K3059 | 4.00 | 197.98 | -0.20% | |
Waste Connections | CA94106B1013 | 3.83 | 179.39 | +0.53% | |
Thermo Fisher Scientific | US8835561023 | 3.50 | 574.85 | +0.05% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Neutral | Sell | Buy |
Technical Indicators | BUY | Strong Sell | BUY |
Summary | Neutral | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review